CMS Info Systems Limited (CMSINFO)
Outcome of Board Meeting
Q2FY27 results (unaudited):
Consolidated:
Revenue 6.5bn +6.7% y-y (6.1bn)
EBITDA 1.73bn +24.8% y-y
EBITDA margin 26.7% (+390 bps y-y)
PAT 0.81bn +10.3% y-y (0.73bn)
H1FY27 results (unaudited):
Consolidated:
Revenue 12.8bn +3.9% y-y (12.4bn)
EBITDA 3.46bn +16.4% y-y
EBITDA margin 27.0% (+290 bps y-y)
PAT 1.65bn -1.4% y-y (1.67bn)
Q2FY27 results (unaudited):
Standalone:
Revenue 6.0bn +8.5% y-y (5.6bn)
PAT 0.66bn -11.3% y-y (0.75bn)
H1FY27 results (unaudited):
Standalone:
Revenue 11.9bn +4.6% y-y (11.4bn)
PAT 1.83bn +15.4% y-y (1.59bn)
FY26 results (audited):
Consolidated:
Revenue 24.9bn
PAT 1.67bn
FY26 results (audited):
Standalone:
Revenue 22.7bn
PAT 2.85bn
Commentary: Fourth consecutive quarter of record services revenue; Technology & Payment Solutions now 20% of services revenue, growing rapidly with a 33%+ CAGR since FY22.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 CMSINFO — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add CMSINFO to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on CMS Info Systems Limited
Important.
The summary above is generated automatically from CMS Info Systems Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.